AACR 2025 - Advancing Oncology Research and Minimal Residual Disease Detection with Inocras’s Whole Genome Cancer Platform

In this presentation from AACR 2025, Inocras outlines how it has implemented Ultima technology into its WGS cancer profiling workflow, CancerVision™, as well as its ultra-sensitive MRD assay, MRDVision™. The session includes talks from Erin-Connolly-Strong (Chief Medical Officer, Inocras), Dr. Majd Al Assaad (Sr. Research Fellow, Weill Cornell Medicine), and a fireside chat including Ariel Jaimovich (VP, Applications) from Ultima Genomics.